معرفی
Dr. Iris Beldhuis is a researcher at the University of Groningen specializing in the intersection of cardiology and nephrology, with particular focus on heart failure and renal function. Her work contributes to UN Sustainable Development Goals related to health and well-being.
Her research interests span Acute Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), Renal Function in Heart Failure, and Cardiorenal Syndrome. She investigates critical aspects including decongestion therapies, diuretic management, biomarkers like natriuretic peptides, and the impact of obesity on kidney outcomes in heart failure patients.
Analysis of her recent publications reveals a strong emphasis on clinical trials and translational research, particularly examining the safety and efficacy of heart failure treatments in patients with comorbid kidney conditions. Her work frequently addresses the challenges of treating heart failure patients who are typically excluded from clinical trials due to renal complications.
Dr. Beldhuis actively engages with the public and medical community through academic presentations and media appearances, including notable contributions to Dutch media outlets like UMCG regarding the safety of heart failure medications in patients with kidney problems. Her 2023 thesis Renal perspectives on heart failure therapies represents a significant contribution to understanding the complex relationship between cardiac and renal systems in heart failure management.
